Enfusion, Inc. (ENFN): Price and Financial Metrics
ENFN Price/Volume Stats
| Current price | $8.87 | 52-week high | $14.61 |
| Prev. close | $8.68 | 52-week low | $7.37 |
| Day low | $8.60 | Volume | 188,020 |
| Day high | $8.90 | Avg. volume | 425,658 |
| 50-day MA | $9.15 | Dividend yield | N/A |
| 200-day MA | $9.75 | Market Cap | 1.09B |
ENFN Stock Price Chart Interactive Chart >
ENFN POWR Grades
- Growth is the dimension where ENFN ranks best; there it ranks ahead of 83.76% of US stocks.
- ENFN's strongest trending metric is Growth; it's been moving down over the last 177 days.
- ENFN ranks lowest in Value; there it ranks in the 20th percentile.
ENFN Stock Summary
- ENFUSION INC's stock had its IPO on October 21, 2021, making it an older stock than only 2.92% of US equities in our set.
- ENFN's current price/earnings ratio is 197.02, which is higher than 97.23% of US stocks with positive earnings.
- The price/operating cash flow metric for ENFUSION INC is higher than 92.91% of stocks in our set with a positive cash flow.
- Stocks that are quantitatively similar to ENFN, based on their financial statements, market capitalization, and price volatility, are NMRK, EZPW, CNM, QSR, and FPH.
- To check out ENFUSION INC's SEC filings, go to the company's page on browse-edgar?action=getcompany&CIK=0001868912.
ENFN Valuation Summary
- In comparison to the median Technology stock, ENFN's price/earnings ratio is 669.53% higher, now standing at 197.
- Over the past 23 months, ENFN's price/earnings ratio has gone down 354.5.
Below are key valuation metrics over time for ENFN.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| ENFN | 2023-09-22 | 6.8 | 23.0 | 197.0 | 168.3 |
| ENFN | 2023-09-21 | 6.8 | 23.2 | 198.8 | 169.8 |
| ENFN | 2023-09-20 | 6.9 | 23.3 | 199.9 | 170.7 |
| ENFN | 2023-09-19 | 6.9 | 23.4 | 200.5 | 171.3 |
| ENFN | 2023-09-18 | 6.7 | 22.7 | 195.3 | 166.7 |
| ENFN | 2023-09-15 | 6.6 | 22.4 | 192.2 | 164.1 |
Enfusion, Inc. (ENFN) Company Bio
Enfusion Inc. offers software-as-a-service for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It provides portfolio management system, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and order and execution management system that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. The company also offers accounting/general ledger system, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion analytics system, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered services. Enfusion Inc. was incorporated in 2021 and is headquartered in Chicago, Illinois.
Latest ENFN News From Around the Web
Below are the latest news stories about ENFUSION INC that investors may wish to consider to help them evaluate ENFN as an investment opportunity.
Is Enfusion, Inc. (NYSE:ENFN) Trading At A 30% Discount?Key Insights Using the 2 Stage Free Cash Flow to Equity, Enfusion fair value estimate is US$12.93 Enfusion's US$9.11... |
The 3 Most Undervalued Under-$10 Stocks to Buy in September 2023Undervalued stocks are not just found in older industries; rather, many can be found in emerging spaces as well. |
Enfusion Announces Closing of New $100 Million Credit FacilityNEW YORK & LONDON & HONG KONG, September 18, 2023--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of cloud-native software-as-a-service (SaaS) solutions for investment managers, announced today that on September 15, 2023, it entered into a new $100 million revolving credit facility. The lenders under the credit facility are primarily a syndicate of Enfusion’s relationship banks, including Bank of America, N.A. The credit facility matures on September 15, 2028 and includes an accord |
Enfusion (NYSE:ENFN) Will Be Hoping To Turn Its Returns On Capital AroundIf we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Ideally, a... |
Here's What Key Metrics Tell Us About Enfusion, Inc. (ENFN) Q2 EarningsWhile the top- and bottom-line numbers for Enfusion, Inc. (ENFN) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. |
ENFN Price Returns
| 1-mo | 6.74% |
| 3-mo | -20.09% |
| 6-mo | -15.52% |
| 1-year | -25.34% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -8.27% |
| 2022 | -53.82% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
Loading social stream, please wait...